Hum. Reprod. Advance Access originally published online on June 21, 2007
Human Reproduction 2007 22(8):2075-2079; doi:10.1093/humrep/dem158
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEW DEBATE |
Coming soon to your clinic: patient-friendly ART
1 Bioethics Institute Ghent, Ghent University, Blandijnberg 2, 9000 Gent, Belgium 2 Genk Institute for Fertility Treatment, Department of Obstetrics and Gynaecology, Genk, Belgium
3 Correspondence address. Tel./Fax: 0032 16 620 767; E-mail: guido.pennings{at}ugent.be
The current practice in medically assisted reproduction is still too exclusively focused on effectiveness and success rates. This has a number of considerable, and more importantly, avoidable drawbacks. Single embryo transfer was an important move away from this model to include safety and welfare of mother and child. Patient-friendly ART goes one big step further. It is composed of a mix of four criteria: cost-effectiveness, equity of access, minimal risk for mother and child and minimal burden for patients. All four components have a strong normative ethical basis: cost-effectiveness relies on the optimal use of community resources to maximise well-being; equity of access is based on justice, minimal risk is founded on the fundamental non-maleficence rule and minimal burden is largely based on the autonomy principle. The inclusion of the four criteria in decision-making about treatment would express these values in clinical practice.
Key words: patient-friendly IVF/cost-effectiveness/ethics/risk/psychology
Submitted on March 18, 2007; resubmitted on April 18, 2007; accepted on May 1, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Devroey, R. Boostanfar, N.P. Koper, B.M.J.L. Mannaerts, P.C. IJzerman-Boon, B.C.J.M. Fauser, and on behalf of the ENGAGE Investigators A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod., December 1, 2009; 24(12): 3063 - 3072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomas, and B. C.J.M. Fauser Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum. Reprod., April 1, 2009; 24(4): 764 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pennings and for the ESHRE Task Force on Ethics and Law Reply: Adapting infertility treatment to religious beliefs Hum. Reprod., December 1, 2008; 23(12): 2867 - 2868. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ombelet False perceptions and common misunderstandings surrounding the subject of infertility in developing countries ESHRE Monogr, July 1, 2008; 2008(1): 8 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pennings Ethical issues of infertility treatment in developing countries ESHRE Monogr, July 1, 2008; 2008(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. W.H. van Empel, W. L.D.M. Nelen, R. P.M.G. Hermens, and J. A.M. Kremer Coming soon to your clinic: high-quality ART Hum. Reprod., June 1, 2008; 23(6): 1242 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nargund, B.C.J.M. Fauser, N.S. Macklon, W. Ombelet, K. Nygren, R. Frydman, and for the Rotterdam ISMAAR Consensus Group on Termin The ISMAAR proposal on terminology for ovarian stimulation for IVF Hum. Reprod., November 1, 2007; 22(11): 2801 - 2804. [Abstract] [Full Text] [PDF]
|
|